193 related articles for article (PubMed ID: 33611700)
1. Establishment and characterization of NCC-SS4-C1: a novel patient-derived cell line of synovial sarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Ono T; Sei A; Takeshita F; Sugaya J; Iwata S; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2021 May; 34(3):998-1007. PubMed ID: 33611700
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of NCC-SS3-C1: a novel patient-derived cell line of synovial sarcoma.
Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Sugaya J; Iwata S; Yoshida A; Kawai A; Kondo T
Hum Cell; 2020 Jul; 33(3):877-885. PubMed ID: 32274656
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of NCC-SS5-C1: a novel patient-derived cell line of synovial sarcoma.
Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Akiyama T; Sugaya J; Kojima N; Yoshida A; Kawai A; Kondo T
Hum Cell; 2022 Jul; 35(4):1290-1297. PubMed ID: 35655041
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line.
Kito F; Oyama R; Takai Y; Sakumoto M; Shiozawa K; Qiao Z; Uehara T; Yoshida A; Kawai A; Kondo T
Hum Cell; 2018 Apr; 31(2):167-174. PubMed ID: 29450702
[TBL] [Abstract][Full Text] [Related]
5. A Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma.
Baranov E; McBride MJ; Bellizzi AM; Ligon AH; Fletcher CDM; Kadoch C; Hornick JL
Am J Surg Pathol; 2020 Jul; 44(7):922-933. PubMed ID: 32141887
[TBL] [Abstract][Full Text] [Related]
6. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1.
Oyama R; Kito F; Sakumoto M; Shiozawa K; Toki S; Endo M; Yoshida A; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2018 May; 54(5):392-399. PubMed ID: 29626278
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo.
Takenaka S; Naka N; Araki N; Hashimoto N; Ueda T; Yoshioka K; Yoshikawa H; Itoh K
Int J Oncol; 2010 Apr; 36(4):823-31. PubMed ID: 20198325
[TBL] [Abstract][Full Text] [Related]
8. Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.
Carmody Soni EE; Schlottman S; Erkizan HV; Uren A; Toretsky JA
Clin Orthop Relat Res; 2014 Mar; 472(3):874-82. PubMed ID: 23716114
[TBL] [Abstract][Full Text] [Related]
9. A novel FISH assay for SS18-SSX fusion type in synovial sarcoma.
Surace C; Panagopoulos I; Pålsson E; Rocchi M; Mandahl N; Mertens F
Lab Invest; 2004 Sep; 84(9):1185-92. PubMed ID: 15208645
[TBL] [Abstract][Full Text] [Related]
10. Detection of Rare Variant of SS18-SSX1 Fusion Gene and Mutations of Important Cancer-Related Genes in Synovial Sarcoma of the Lip: Gene Analyses of a Case and Literature Review.
Mikami T; Kurose A; Javed F; Takeda Y
J Oral Maxillofac Surg; 2015 Aug; 73(8):1505-15. PubMed ID: 25959879
[TBL] [Abstract][Full Text] [Related]
11. BCOR upregulation in a poorly differentiated synovial sarcoma with SS18L1-SSX1 fusion-A pathologic and molecular pitfall.
Kao YC; Sung YS; Zhang L; Kenan S; Singer S; Tap WD; Swanson D; Dickson BC; Antonescu CR
Genes Chromosomes Cancer; 2017 Apr; 56(4):296-302. PubMed ID: 27914109
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of NCC-UPS3-C1: a novel patient-derived cell line of undifferentiated pleomorphic sarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Akiyama T; Sugaya J; Nakatani F; Kojima N; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2022 Jan; 35(1):384-391. PubMed ID: 34665443
[TBL] [Abstract][Full Text] [Related]
13. Molecular detection of SS18-SSX fusion gene transcripts by cRNA in situ hybridization in synovial sarcoma using formalin-fixed, paraffin-embedded tumor tissue specimens.
Kanemitsu S; Hisaoka M; Shimajiri S; Matsuyama A; Hashimoto H
Diagn Mol Pathol; 2007 Mar; 16(1):9-17. PubMed ID: 17471153
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of NCC-ASPS1-C1: a novel patient-derived cell line of alveolar soft-part sarcoma.
Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Sugaya J; Fukushima S; Yoshida A; Kawai A; Kondo T
Hum Cell; 2020 Oct; 33(4):1302-1310. PubMed ID: 32648033
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of NCC-DDLPS3-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Ono T; Sei A; Takeshita F; Sugaya J; Fukushima S; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2021 May; 34(3):1008-1018. PubMed ID: 33677797
[TBL] [Abstract][Full Text] [Related]
16. Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma.
Mihály D; Nagy N; Papp G; Pápai Z; Sápi Z
Diagn Pathol; 2018 Oct; 13(1):81. PubMed ID: 30326929
[TBL] [Abstract][Full Text] [Related]
17. The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis.
Jones KB; Barrott JJ; Xie M; Haldar M; Jin H; Zhu JF; Monument MJ; Mosbruger TL; Langer EM; Randall RL; Wilson RK; Cairns BR; Ding L; Capecchi MR
Oncogene; 2016 Sep; 35(38):5021-32. PubMed ID: 26947017
[TBL] [Abstract][Full Text] [Related]
18. The clinical implication of SS18-SSX fusion gene in synovial sarcoma.
Ren T; Lu Q; Guo W; Lou Z; Peng X; Jiao G; Sun Y
Br J Cancer; 2013 Oct; 109(8):2279-85. PubMed ID: 24022186
[TBL] [Abstract][Full Text] [Related]
19. Truncated SSX protein suppresses synovial sarcoma cell proliferation by inhibiting the localization of SS18-SSX fusion protein.
Yoneda Y; Ito S; Kunisada T; Morimoto Y; Kanzaki H; Yoshida A; Shimizu K; Ozaki T; Ouchida M
PLoS One; 2013; 8(10):e77564. PubMed ID: 24130893
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a variant SYT-SSX1 synovial sarcoma fusion transcript.
Safar A; Wickert R; Nelson M; Neff JR; Bridge JA
Diagn Mol Pathol; 1998 Oct; 7(5):283-7. PubMed ID: 9990487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]